Riskpilot← Back to searchSign inGet full accessCENTRUM HELSE AS
ASActiveOrg 916988400Storgata 19, 1607 FredrikstadPhysiotherapy activities · NACE 8695Est. 20160 employees
Revenue 2025
NOK 446K
+14% vs 2024
EBITDA margin
63.3%
+52% vs 2024
Equity ratio
84.9%
Financial strength
Net profit 2025
NOK 134K
+240% vs 2024
| Revenue | NOK 446K | +14% |
| EBITDA | NOK 282K | +52% |
| Net profit | NOK 134K | +240% |
| Total assets | NOK 766K | +14% |
| Equity | NOK 651K | +26% |
| Employees | 0 | — |
Legal name
CENTRUM HELSE AS
Org number
916988400
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
20. april 2016
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Rehabilitering, opptrening og forebyggende helsearbeid. I tillegg kommer andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Storgata 19, 1607 Fredrikstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 307 | 318 | 362 | 392 | 446 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 183 | 131 | 106 | 186 | 282 |
| Depreciation & amort. | −105 | −105 | −105 | −111 | −110 |
| EBIT | 78 | 25 | 1 | 75 | 172 |
| Net financials | −4 | −0 | 0 | 0 | −0 |
| Profit before tax | 73 | 25 | 1 | 75 | 172 |
| Tax | 24 | 83 | −16 | 36 | 38 |
| Net profit | 50 | −57 | 17 | 39 | 134 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 642 | 618 | 615 | 674 | 766 |
| Equity | 543 | 461 | 478 | 517 | 651 |
| Long-term debt | 0 | 67 | 34 | 41 | 26 |
| Short-term debt | 99 | 91 | 103 | 116 | 90 |
| Total debt | 99 | 158 | 137 | 157 | 115 |
EBITDA margin
63.3%
This company
15.8%
Market median
+301% vs market
20212025
Equity ratio
84.9%
This company
38.2%
Market median
+122% vs market
20212025
Return on equity
20.6%
This company
18.4%
Market median
+12% vs market
20212025
Net profit margin
30.1%
This company
8.1%
Market median
+272% vs market
20212025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20212025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 40% | 40% | 2022 | |
| Individual | 12% | 12% | 2022 | |
| Individual | 12% | 12% | 2022 | |
| Individual | 12% | 12% | 2022 | |
| Individual | 12% | 12% | 2022 | |
| Individual | 12% | 12% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CENTRUM HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sigurd Ahn Mikkelsen | Board of Directors | 0 companies |
| Ann-Sofi Slettevold Thorsen | Board of Directors | 0 companies |